Mylan, Generic Copaxone Punish Teva
Mylan (MYL) finally received approval for a generic version Teva's (TEVA) Copaxone. The news broke Tuesday after-hours. Wednesday TEVA fell 14% and MYL was...
RegeneRX V. Aldeyra – Who Hits The $2 Billion Dry-Eye Jackpot?
Allergan's (AGN) recent ploy to sell Restasis patents to the St. Regis Mohawk Tribe was perplexing to many. It also brought attention to Allergan's...
Shire Sues Allergan In Dry-Eye Donnybrook
Earlier this week Shire (SHPG) sued Allergan (AGN) for allegedly blocking access to its dry-eye drug from certain Medicare Part D drug plans:
Shire ...
BlackBerry – The Future Is Now
I have been a BlackBerry (BBRY) bull for some time now. Critics have predicted the company's demise due to the run off of SAF...
OJ Simpson Released After Nine Years
OJ Simpson was released on parole overnight in Nevada after spending nine years for a botched robbery. Simpson served nine years of a 33...
Teva Kicks The Can Down The Road
Last week Teva's (TEVA) shares rose nearly 3%, spurred by amendments to the company's U.S. dollar and Japanese yen term loan and revolving credit...
Valeant Is ‘Desert Thirsty’ For Equity
Valeant (VRX) spooked investors last week when it filed an application to raise additional capital with the securities regulator in Quebec:
Valeant sparked expectations that...
Alexion – Canada’s Drug Price Watchdog Orders Price Cut For Soliris
Last week Canada's Patented Medicine Prices Review Board ("PMPRB") Hearing Panel ordered Alexion Pharmaceuticals (ALXN) to reduce the price of its top-selling drug Soliris:
The...
Seadrill Kicks The Can Down The Road
Highly-indebted Seadrill has been skating on thin ice ever since oil prices diverged to the downside nearly three years ago. Earlier this month it...
Trump, Jerry Jones Spoke About Handling Black Players; *Crickets* On Allergan
Last weekend President Trump set off a fire storm when he suggested that owners fire "son of bitch players" who do not stand for...
